Ethnic Differences in 90-Day Poststroke Medication Adherence.
Mexican Americans
anticoagulants
diabetes mellitus
hypertension
medication adherence
Journal
Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
pubmed:
16
5
2019
medline:
22
1
2020
entrez:
16
5
2019
Statut:
ppublish
Résumé
Background and Purpose- We assessed ethnic differences in medication adherence 3 months poststroke in a population-based study as an initial step in investigating the increased stroke recurrence risk in Mexican Americans compared with non-Hispanic whites. Methods- Ischemic stroke cases from 2008 to 2015 from the Brain Attack Surveillance in Corpus Christi project in Texas were followed prospectively for 3 months poststroke to assess medication adherence. Medications in 5 drug classes were analyzed: statins, antiplatelets, anticoagulants, antihypertensives, and antidepressants. For each drug class, patients were considered adherent if they reported never missing a dose in a typical week. The χ
Identifiants
pubmed: 31084331
doi: 10.1161/STROKEAHA.118.024249
pmc: PMC6538428
mid: NIHMS1527013
doi:
Types de publication
Clinical Trial
Comparative Study
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1519-1524Subventions
Organisme : NINDS NIH HHS
ID : R01 NS038916
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS070941
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Ethn Dis. 2004 Autumn;14(4):520-6
pubmed: 15724771
Med Decis Making. 2001 Jan-Feb;21(1):28-36
pubmed: 11206944
Health Aff (Millwood). 2011 Jan;30(1):91-9
pubmed: 21209444
Hawaii J Med Public Health. 2014 Jan;73(1):11-8
pubmed: 24470982
Stroke. 2007 Dec;38(12):3198-204
pubmed: 17962589
Stroke. 1994 Feb;25(2):333-7
pubmed: 8303740
Ann Neurol. 2006 Oct;60(4):469-75
pubmed: 16927332
Arch Intern Med. 1994 Jul 11;154(13):1449-57
pubmed: 8018000
Clin Med Res. 2013 Jun;11(2):54-65
pubmed: 23580788
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):451-7
pubmed: 20031876
Arch Intern Med. 2007 Sep 24;167(17):1853-60
pubmed: 17893306
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Stroke. 1998 Dec;29(12):2491-500
pubmed: 9836757
J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):290-3
pubmed: 19521251
Neurology. 2017 May 9;88(19):1839-1848
pubmed: 28404800
Clin Ther. 2009 Oct;31(10):2178-88; discussion 2150-1
pubmed: 19922889
Ann Pharmacother. 2009 Feb;43(2):185-93
pubmed: 19193586
MMWR Morb Mortal Wkly Rep. 2009 May 1;58(16):421-6
pubmed: 19407734
Eur J Neurol. 2001 Jul;8(4):315-9
pubmed: 11422427
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
Stroke. 2000 Apr;31(4):858-62
pubmed: 10753988
Ann Neurol. 2013 Dec;74(6):778-85
pubmed: 23868398
J Gen Intern Med. 2011 Oct;26(10):1175-82
pubmed: 21533823
Stroke. 2002 Apr;33(4):1034-40
pubmed: 11935057
J Gen Intern Med. 2013 May;28(5):675-82
pubmed: 23288379
Stroke. 2004 Apr;35(4):1024
pubmed: 15053002
Stroke. 1999 Feb;30(2):338-49
pubmed: 9933269
Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004222
pubmed: 29371220
Neurology. 2011 Sep 20;77(12):1182-90
pubmed: 21900638
Stroke. 2010 Jul;41(7):1445-9
pubmed: 20508191